Insight journal - Therapy

Top 15 Most Partnered Therapeutic Targets

Posted on 13 August 2013

Tags: , , ,

A recent study by Current Partnering identifies the most partnered therapeutic targets in recent years. Updated version of this article available here Top 15 most partnered therapeutic trends in pharma industry 2014.

The study was conducted by analysing the number of partnering deals listed at Current Agreements, a leading deals and alliances database for the life sciences.

The following figure provides a top level overview of partnering activity based on broad therapeutic

Figure 1: Partnering trends by therapy area 2007-2013

Therapy partnering frequency

Source: Current Partnering, 2013

The study identified 35 therapeutic targets where more than 100 partnering deals have been announced during the period 2007 to mid-2013.

This article seeks to review the top 15 specific therapeutic targets based on most partnering deals announced.

The full report can be viewed here: Trends in Therapeutic Partnering

Not surprisingly the list is dominated by chronic and life threatening conditions, many of which present in later stages of life. Examples include numerous cancers, infectives, other chronic later life conditions.

These therapeutic areas represent an attractive opportunity and unmet need for many big pharma and big biotech companies.

As a result, the deal making is dominated by top pharma/biotech companies in-licensing from smaller companies in return for upfront, milestone and royalty streams should product candidates make it to market.

In addition, there is much activity between companies/academia for discovery research in these therapeutic areas.

The following is a countdown of the top 15 therapeutic areas in reverse order.

#15. Solid tumors

Number of partnering deals announced: 650

Deal dollar value for partnering: $32.67bn

Solid tumor deal frequency

Solid tumor partnering by year

Source: Current Partnering, 2013

Solid tumor partnering by stage of development

Solid tumor partnerng by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Solid Tumor Cancer Partnering 2007-2013

 

#14. Colorectal cancer

Number of partnering deals announced: 206

Deal dollar value for partnering: $1.99bn

Colorectal cancer deal frequency

Colorectal cancer partnering by year

Source: Current Partnering, 2013

Colorectal cancer partnering by stage of development

Colorectal cancer partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Colorectal Cancer Partnering 2007-2013

 

#13. Rheumatoid arthritis

Number of partnering deals announced: 229

Deal dollar value for partnering: $19.3bn

Rheumatoid arthritis deal frequency

Rheumatoid arthritis partnering by year

Source: Current Partnering, 2013

Rheumatoid arthritis partnering by stage of development

Rheumatoid arthritis partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Rheumatoid Arthritis Partnering 2007-2013

 

#12. Nutrition

Number of partnering deals announced: 234

Deal dollar value for partnering: $13.94bn

Nutrition deal frequency

Nutrition partnering by year

Source: Current Partnering, 2013

Nutrition partnering by stage of development

Nutrition partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Nutrition & Vitamins Partnering 2007-2013

 

#11. Prostate cancer

Number of partnering deals announced: 238

Deal dollar value for partnering: $4.83bn

Prostate cancer deal frequency

Prostate cancer partnering by year

Source: Current Partnering, 2013

Prostate cancer partnering by stage of development

Prostate cancer partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Prostate Cancer Partnering 2007-2013

 

#10. Leukemia

Number of partnering deals announced: 254

Deal dollar value for partnering: $11.75bn

Leukemia deal frequency

Leukemia partnerng by year

Source: Current Partnering, 2013

Leukemia partnering by stage of development

Leukemia partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Leukemia Partnering 2007-2013

 

#9. Wound healing

Number of partnering deals announced: 260

Deal dollar value for partnering: $1.65bn

Wound healing deal frequency

Wound healing partnering by year

Source: Current Partnering, 2013

Wound healing partnering by stage of development

Wound healing partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Wound Healing Partnering 2007-2013

 

#8. Lung cancer

Number of partnering deals announced: 280

Deal dollar value for partnering: $6.54bn

Lung cancer deal frequency

Lung cancer partnering by year

Source: Current Partnering, 2013

Lung cancer partnering by stage of development

Lung cancer partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Lung Cancer Partnering 2007-2013

 

#7. Inflammation

Number of partnering deals announced: 280

Deal dollar value for partnering: $16.98bn

Inflammation deal frequency

Inflammation partnering by year

Source: Current Partnering, 2013

Inflammation partnering by stage of development

Inflammation partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Inflammatory Partnering 2007-2013

 

#6. Alzheimer’s disease

Number of partnering deals announced: 292

Deal dollar value for partnering: $11.33bn

Alzheimer’s disease deal frequency

Alzheimers disease partnering by year

Source: Current Partnering, 2013

Alzheimer’s disease partnering by stage of development

Alzheimers disease partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Alzheimer’s Disease Partnering 2007-2013

 

#5. HIV

Number of partnering deals announced: 331

Deal dollar value for partnering: $5bn

HIV deal frequency

HIV partnering by year

Source: Current Partnering, 2013

HIV partnering by stage of development

HIV partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: HIV Partnering 2007-2013

 

#4. Influenza

Number of partnering deals announced: 332

Deal dollar value for partnering: $7.61bn

Influenza deal frequency

Influenza partnering by year

Source: Current Partnering, 2013

Influenza partnering by stage of development

Influenza partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Influenza Partnering 2007-2013

 

#3. Breast cancer

Number of partnering deals announced: 370

Deal dollar value for partnering: $4.05bn

Breast cancer deal frequency

Breast cancer partnering by year

Source: Current Partnering, 2013

Breast cancer partnering by stage of development

Breast cancer partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Breast Cancer Partnering 2007-2013

 

#2. Pain

Number of partnering deals announced: 480

Deal dollar value for partnering: $13.7bn

Pain deal frequency

Pain partnering by year

Source: Current Partnering, 2013

Pain partnering by stage of development

Pain partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Pain Partnering 2007-2013

 

#1. Diabetes

Number of partnering deals announced: 650

Deal dollar value for partnering: $36.72bn

Diabetes deal frequency

Diabetes partnering by year

Source: Current Partnering, 2013

Diabetes partnering by stage of development

Diabetes partnering by stage

Source: Current Partnering, 2013

All data: 2007 to mid-2013

To obtain comprehensive coverage of every deal announced:

  • All 35 therapeutic areas: Trends in Therapeutic Partnering
  • This therapeutic area only: Diabetes Partnering 2007-2013

 

Full list of top 35 therapeutic targets for partnering since 2007 can be found in the table of contents of the report: Trends in Therapeutic Partnering

 

Related

Report: Trends in Therapeutic Partnering

View: Full list of therapeutic partnering reports

Report: Partnering Deals and Alliances with Big Pharma                                                  

Report: Partnering Deals and Alliances with Big Biotech

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply